Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Red Cat Holdings (RCAT) Reports Q3 Revenue Growth but Widens Losses and Withdraws Guidance

Red Cat Holdings (RCAT) Reports Q3 Revenue Growth but Widens Losses and Withdraws Guidance

Key Takeaways

  • Red Cat Holdings reported fiscal third-quarter 2026 revenue of $11.8 million, up 22% year over year from $9.6 million, but well short of the consensus estimate of roughly $40.7 million.
  • The net loss widened to $40.4 million, or $0.26 per share, versus a net loss of $16.0 million, or $0.16 per share, in the prior-year period — missing the consensus estimate of a $0.20 per share loss.
  • Gross margin fell to 0.6% from 6.6% a year earlier, pressured by inventory scrap, warranty costs, returns, and underused manufacturing capacity.
  • Management withdrew its fiscal 2026 revenue target (previously $150 million to $180 million), citing delayed contract awards and the FANG FPV drone not making the Drone Dominance 2 finalist list.
  • The company ended the quarter with $242.7 million in cash, while nine-month operating cash outflow reached $156.8 million and inventory climbed to $117.2 million.
  • Red Cat combined its Teal and FlightWave units into Red Cat Aerial, cutting its workforce and recurring expenses by about 10%.

Earnings Context and Why It Matters

Red Cat Holdings has become one of the most closely watched names in the military drone sector, with its Teal unit delivering small unmanned aerial systems to the U.S. Army and allied forces. The company's growth narrative has been driven by large defense contracts and production scale-up, but execution has been uneven. After revenue more than tripled in the first half of fiscal 2026, investors entered this report looking for confirmation that the company could convert its order backlog and manufacturing capacity into consistent shipments and improving margins. This quarter's results matter because they test both the credibility of management's guidance and the company's path toward profitability. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

For the fiscal third quarter of 2026, RCAT reported revenue of $11.8 million, an increase of 22% from $9.6 million in the prior-year period. Growth reflected drone deliveries to the U.S. Air Force and other customers, though the figure came in well below the roughly $40.7 million consensus estimate.

The company posted a net loss of $40.4 million, or $0.26 per share, compared with a net loss of $16.0 million, or $0.16 per share, a year earlier. The loss per share was $0.06 worse than the consensus estimate of a $0.20 loss. Gross profit was approximately $0.1 million, representing a 0.6% gross margin, down sharply from 6.6% a year ago.

On guidance, management withdrew its fiscal 2026 revenue target, which had previously stood at $150 million to $180 million. The company attributed the decision to slower-than-expected funding and contract awards, as well as the exclusion of its FANG FPV platform from the Drone Dominance 2 finalist round. Operating expenses rose to about $43.5 million from $18.2 million in the prior-year period, reflecting continued investment in engineering, testing, and infrastructure.

Market Reaction and Investor Sentiment

Shares of RCAT declined roughly 7% during Monday's session, trading around $3.53, as investors digested the revenue miss, the wider-than-expected loss, and the withdrawal of full-year guidance. The stock has been under sustained pressure in recent months, down more than 60% over the prior three months, reflecting growing skepticism about the company's ability to meet its ambitious delivery timelines.

Sentiment heading into the report was already cautious, and the guidance reset compounded concerns. Investors appear focused less on the year-over-year revenue growth and more on the widening losses, deteriorating gross margin, and the execution challenges flagged around both the Drone Dominance 2 competition and the FlightWave division. The market's reaction signals that near-term credibility around the path to profitability has become the central question.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be watching whether Red Cat Holdings can stabilize its cost structure and translate its substantial inventory and production capacity into actual shipments. The integration of Teal and FlightWave into Red Cat Aerial is intended to lower recurring expenses, but the company will need to demonstrate that these cost reductions flow through to narrower losses in the quarters ahead.

The withdrawal of the fiscal 2026 revenue target removes a key benchmark that investors had used to gauge progress. With the FANG FPV platform no longer in the Drone Dominance 2 finalist round, attention shifts to the company's other contract opportunities, including deliveries to the U.S. Army, the Japan Ground Self-Defense Force, and allied NATO customers.

Margin recovery will be another critical factor. The 0.6% gross margin reflects scrap, warranty costs, returns, and excess capacity, and investors will look for evidence that manufacturing efficiency is improving. Finally, the proposed Steyr Motors acquisition, if it proceeds through its tender process and approvals, could reshape the company's product portfolio and be a notable catalyst to monitor.

Exploring AI Tools for Stock Analysis

In my own research process, I find Tickeron’s AI Screener helpful for quickly filtering defense and drone stocks by technical patterns, fundamentals, and momentum signals. It lets users scan thousands of names with customizable criteria and can highlight ideas that might otherwise take hours to uncover manually. This kind of tool has become part of how I cross-check sector trends before forming a fuller view on names like RCAT.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RCAT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RCAT sees MACD Histogram just turned negative

RCAT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 36 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RCAT as a result. In 63 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for RCAT entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +32.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCAT advanced for three days, in 233 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.309) is normal, around the industry mean (5.050). P/E Ratio (-5.050) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.367).

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 36.83B. The market cap for tickers in the group ranges from 4.49 to 1.77T. SPCX holds the highest valuation in this group at 1.77T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -12%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was -32%. HAWK experienced the highest price growth at 23%, while SPCE experienced the biggest fall at -58%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 54
Price Growth Rating: 64
SMR Rating: 78
Profit Risk Rating: 78
Seasonality Score: -12 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
2800 South West Temple
Phone
+1 800 466-9152
Employees
244
Web
https://www.redcat.red
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.